LYGEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lygen, and what generic alternatives are available?
Lygen is a drug marketed by Alra and is included in three NDAs.
The generic ingredient in LYGEN is chlordiazepoxide hydrochloride. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lygen
A generic version of LYGEN was approved as chlordiazepoxide hydrochloride by CHARTWELL RX on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LYGEN?
- What are the global sales for LYGEN?
- What is Average Wholesale Price for LYGEN?
Summary for LYGEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Patent Applications: | 6,883 |
| DailyMed Link: | LYGEN at DailyMed |
US Patents and Regulatory Information for LYGEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alra | LYGEN | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085107-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alra | LYGEN | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085009-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alra | LYGEN | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085108-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
